Research Lab Results for cancer
Ami Shah LabLab WebsitePrincipal Investigator:
Ami Shah, M.D.
Researchers in the Ami Shah Lab study scleroderma and Raynaud’s phenomenon. We examine the rela...tionship between cancer and scleroderma, with a focus on how and if cancer causes scleroderma to develop in some patients. We are currently conducting clinical research to study ways to detect cardiopulmonary complications in patients with scleroderma, biological and imaging markers of Raynaud’s phenomenon, and drugs that improve aspects of scleroderma. view moreResearch Areas: Raynaud's phenomenon, cancer, scleroderma, drugs, cardiovascular diseases
Amit Pahwa LabPrincipal Investigator:
Amit Pahwa, M.D.
The Amit Pahwa Lab conducts research on a variety of topics within internal medicine. Our most ...recent studies have explored misanalysis of urinalysis results, urinary fractional excretion indices in the evaluation of acute kidney injury and nocturnal enuresis as a risk factor for falls in older women. We also investigate cancer diagnostics and treatments. In this area, our recent research has included studying cutaneous shave biopsies for diagnosing primary colonic adenocarcinoma as well as growth inhibition and apoptosis in human brain tumor cell lines using selenium. view moreResearch Areas: acute kidney injury, cancer, internal medicine, urology
Andrew Feinberg LaboratoryLab WebsitePrincipal Investigator:
Andrew Feinberg, M.D., M.P.H.
The Feinberg Laboratory studies the epigenetic basis of normal development and disease, includi...ng cancer, aging and neuropsychiatric illness. Early work from our group involved the discovery of altered DNA methylation in cancer as well as common epigenetic (methylation and imprinting) variants in the population that may be responsible for a significant population-attributable risk of cancer.Research Areas: autism, cancer, epigenetics, schizophrenia, human development, aging, DNA, genomics, neuropsychiatric disease
Over the last few years, we have pioneered the field of epigenomics (i.e., epigenetics at a genome-scale level), founding the first NIH-supported NIH epigenome center in the country and developing many novel tools for molecular and statistical analysis. Current research examines the mechanisms of epigenetic modification, the epigenetic basis of cancer, the invention of new molecular, statistical, and epidemiological tools for genome-scale epigenetics and the epigenetic basis of neuropsychiatric disease, including schizophrenia and autism. view more
Andrew Laboratory: Center for Cell DynamicsLab WebsitePrincipal Investigator:
Deborah Andrew, Ph.D., M.S.
Researchers in the Center for Cell Dynamics study spatially and temporally regulated molecular ...events in living cells, tissues and organisms. The team develops and applies innovative biosensors and imaging techniques to monitor dozens of critical signaling pathways in real time. The new tools help them investigate the fundamental cellular behaviors that underlie embryonic development, wound healing, cancer progression, and functions of the immune and nervous systems. view moreResearch Areas: immunology, cancer, epithelial tube, nervous system, molecular biology
Anne Marie Lennon LabPrincipal Investigator:
Anne Marie O'Broin Lennon, M.B.B.Ch., Ph.D.
Radiology and Radiological Science
The Lennon Lab does clinical and translational research on endoscopic ultrasound, esophageal ca...ncer, gastric cancer, gastroenterology, pancreatic cancer, pancreatic cysts, therapeutic endoscopy, Von Hippel-Lindau (VHL)Research Areas: Von Hippel-Lindau (VHL), gastroenterology, pancreatic cancer, Endoscopic Ultrasound, Esophageal Cancer, Pancreatic Cysts, Therapeutic Endoscopy, Gastric Cancer
Antony Rosen LabPrincipal Investigator:
Antony Rosen, M.B.Ch.B., M.S.
Research in the Antony Rosen Lab investigates the mechanisms shared by the autoimmune rheumatic... diseases such as lupus, myositis, rheumatoid arthritis, scleroderma and SjogrenÕs syndrome. We focus on the fate of autoantigens in target cells during various circumstances, such as viral infection, relevant immune effector pathways and exposure to ultraviolet radiation. Our recent research has sought to define the traits of autoantibodies that enable them to induce cellular or molecular dysfunction. We also work to better understand the mechanisms that form the striking connections between autoimmunity and cancer. view moreResearch Areas: myositis, lupus, rheumatology, Sjogren's syndrome, scleroderma, autoimmune rheumatic diseases, rheumatoid arthritis
Brain Cancer Biology and Therapy LabLab WebsitePrincipal Investigator:
Gregory Riggins, M.D., Ph.D.
The goal of the Johns Hopkins Brain Cancer Biology and Therapy Laboratory is to locate the gene...tic and genomic changes that lead to brain cancer. These molecular changes are evaluated for their potential as therapeutic targets and are often mutated genes, or genes that are over-expressed during the development of a brain cancer. The brain cancers that the Riggins Laboratory studies are medulloblastomas and glioblastomas. Medulloblastomas are the most common malignant brain tumor for children and glioblastomas are the most common malignant brain tumor for adults. Both tumors are difficult to treat, and new therapies are urgently needed for these cancers. Our laboratory uses large-scale genomic approaches to locate and analyze the genes that are mutated during brain cancer development. The technologies we now employ are capable of searching nearly all of a cancer genome for molecular alterations that can lead to cancer. The new molecular targets for cancer therapy are first located by large scale gene expression analysis, whole-genome scans for altered gene copy number and high throughput sequence analysis of cancer genomes. The alterations we find are then studied in-depth to determine how they contribute to the development of cancer, whether it is promoting tumor growth, enhancing the ability for the cancer to invade into normal tissue, or preventing the various fail-safe mechanisms programmed into our cells. view moreResearch Areas: brain cancer
Brain Tumor Cancer Genetics LabLab WebsitePrincipal Investigator:
Chetan Bettegowda, M.D., Ph.D.
The lab explores the genetic underpinnings that drive the pathogenesis of a variety of primary ...central nervous system neoplasms. We are interested in exploiting genetic changes for both diagnostic and therapeutic purposes. Our lab is currently working on understanding the extreme responders and extreme clinical phenotypes of brain and spinal cord tumors to identify factors that may modulate responses to therapy. view moreResearch Areas: brain tumor genetics, brain tumor
Brennen LabPrincipal Investigator:
W. Nathaniel Brennen, Ph.D.
The Brennen laboratory takes a rigorous, multi-disciplinary, team-based approach towards develo...ping innovative therapeutic and prognostic strategies for prostate cancer with an emphasis on exploiting vulnerabilities within the tumor microenvironment towards this goal. To accomplish this goal, we are strategically pursuing novel therapeutic platforms, including stromal-targeted prodrugs, protoxins, and radiolabeled antibodies, in addition to cell-based therapy and drug delivery; all of which are designed to reduce toxicity to peripheral non-target tissue (i.e. side effects) while maximizing anti-tumor efficacy (i.e. therapeutic benefit). Currently, many of these strategies are focused on overcoming stromal barriers to anti-tumor immune responses such that men suffering from prostate cancer can share in the immense, revolutionary power of immunotherapy that is transforming care for many with advanced disease in other tumor types previously thought to be unmanageable using conventional approaches. Unfortunately, prostate cancer has largely proven refractory to these powerful approaches thus far and requires novel mono- or combinatorial treatment strategies to unleash the full potential of the immune system and generate personalized anti-tumor responses with the capability of producing long-term durable responses or even cures in these men. view moreResearch Areas: prostate cancer, prodrugs, cell-based therapy, tumor microenvironment
Center for NanomedicineLab WebsitePrincipal Investigator:
Justin Hanes, Ph.D.
The Center for Nanomedicine engineers drug and gene delivery technologies that have significant... implications for the prevention, treatment and cure of many major diseases facing the world today. Specifically, we are focusing on the eye, central nervous system, respiratory system, women's health, gastrointestinal system, cancer, and inflammation.Research Areas: central nervous system, respiratory system, nanotechnology, cancer, drugs, women's health, inflammation, eye, gastrointestinal
We are a unique translational nanotechnology effort located that brings together engineers, scientists and clinicians working under one roof on translation of novel drug and gene delivery technologies view more
Cervical Cancer Research LabLab WebsitePrincipal Investigator:
Tzyy-Choou Wu, M.D., Ph.D., M.P.H.
Johns Hopkins is a member of the Specialized Program of Research Excellence (SPORE) in Cervical... Cancer. With a $11.5 million grant from the National Cancer Institute, we are conducting lab, translational and clinical studies to prevent and treat cervical cancers. Previous studies have identified connections between immune system genes and HPV16. Current projects include the development of next-generation HPV vaccines to control HPV-associated precursor lesions and invasive cancer. Our dedicated researchers are working to extend the techniques used in HPV vaccine development to the creation of vaccines targeting other cancers with defined tumor antigens. view moreResearch Areas: HPV vaccines, cervical cancer, HPV
Cervical Dysplasia Research LabLab WebsitePrincipal Investigator:
Cornelia Trimble, M.D.
Gynecology and Obstetrics
We are interested in how immune responses occur in the cervix. The focus of our translational ...research is on developing immune therapies for disease caused by human papillomavirus (HPV). HPV infection causes more cancers than any other virus in the world. Cervical cancer is the most common cancer caused by HPV, and although we have known how to screen for it for over half a century, it remains the second most common cause of cancer death in women. Although the preventive vaccines are a public health milestone, they prevent HPV infections, but are not designed to make immune responses to treat HPV. We are testing different strategies to make immune responses that could treat HPV disease. Our dedicated researchers are working to extend the techniques used in HPV vaccine development to the creation of vaccines targeting other cancers with defined tumor antigens. view moreResearch Areas: cervical cancer, HPV, cancer vaccines
Christine Durand LabPrincipal Investigator:
Christine Durand, M.D.
Dr. Christine Durand, assistant professor of medicine and oncology and member of the Johns Hopk...ins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation.Research Areas: Bone Marrow Transplantation, transplants, infectious disease, AIDS, HIV, Solid Organ Transplantation, hepatitis C
Dr. Durand is supported by multiple grants:
• R01 from the National Institute of Allergy and Infectious Diseases (NIAID) to study HIV-to-HIV organ transplantation in the US.
• K23 from the National Cancer Institute (NCI) to study antiretroviral therapy during bone marrow transplant in HIV-1 infection.
• U01 from the NIAID to study HIV-to-HIV deceased donor kidney transplantation.
U01 from the NIAID to study HIV-to-HIV deceased donor liver transplantation. view more
Claire Snyder LabPrincipal Investigator:
Claire Snyder, Ph.D., M.H.S.
Researchers in the Claire Snyder Lab study the quality of cancer care, with a special focus on ...two areas: the quality of life for cancer patients undergoing treatment and the coordination of care between cancer specialists and primary care providers. As part of our quality-of-life research, we're investigating the use of patient-reported outcome questionnaires in routine oncology practice as well as developing a website for collecting the questionnaires and linking them with the electronic medical record. As part of our cancer-survivorship research, we've conducted large database studies to identify the physician specialties involved in the care of cancer survivors and to determine how that relates to survivors receiving recommended follow-up care. We're also working with investigators in the Sydney Kimmel Comprehensive Cancer Center to develop care strategies for breast cancer survivors. view moreResearch Areas: breast cancer, cancer survivors, cancer, quality of life, care coordination
Constance Monitto LabLab WebsitePrincipal Investigator:
Constance Monitto, M.D.
Anesthesiology and Critical Care Medicine
The Constance Monitto Lab conducts clinical research on pediatric pain management as well as ba...sic science studies on chemotherapy resistance. In our pediatric pain management research, we work to assess the impact of low-dose opioid antagonism on opioid-related side effects, such as nausea and vomiting. We also analyze data on current methods of pediatric pain management in the United States. In addition, our team uses basic science studies to assess the success of epigenetic gene regulation on the development of resistance to chemotherapeutic agents in cancer. view moreResearch Areas: chemotherapy, opioids, epigenetics, gene regulation, pain, pediatrics
Craig Pollack LabPrincipal Investigator:
Craig Pollack, M.D., M.H.S.
Research in the Craig Pollack Lab focuses on cancer prevention and control, particularly prosta...te cancer. Our work aims to understand how the organization environment of health care affects the type and quality of care that patients receive. Other work investigates the broader social context of health and health care— specifically housing, financial hardship and socioeconomic status. view moreResearch Areas: sociodemographics, prostate, cancer, quality of care
Cynthia Sears LaboratoryPrincipal Investigator:
Cynthia Sears, M.D.
Work in the Cynthia Sears Laboratory focuses on the bacterial contributions to the development ...of human colon cancer and the impact of the microbiome on other cancers and the therapy of cancer. The current work involves mouse and human studies to define how enterotoxigenic Bacteroides fragilis, pks+ Escherichia coli, Fusobacterium nucleatum, biofilms and the colonic microbiota induce chronic colonic inflammation and colon cancer. Prospective human studies of the microbiome and biofilms in screening colonoscopy are in progress as are studies to determine if and how the microbiome impacts the response of individuals with cancer to immunotherapy and other cancer therapies.Research Areas: epidemiology, AIDS, microbiome, colon cancer, enterotoxigenic Bacteroides fragilis, chronic colonic inflammation
David Cooper LabPrincipal Investigator:
David Cooper, M.D.
Research in the David S. Cooper Lab focuses primarily on hyperthyroidism and thyroid cancer. To...pics of recent published studies include the NTCTCS staging systems for differentiated thyroid cancer, radioiodine remnant ablation in low-risk differentiated thyroid cancer, and the link between race/ethnicity and the prevalence of thyrotoxicosis in young Americans. view moreResearch Areas: neoplasms, hyperthyroidism, cancer, thyroidectomy, thyroid, Graves’ disease, hypothyroidism
Devreotes LaboratoryLab WebsitePrincipal Investigator:
Peter Devreotes, Ph.D.
The Devreotes Laboratory is engaged in genetic analysis of chemotaxis in eukaryotic cells. Our ...long-term goal is a complete description of the network controlling chemotactic behavior. We are analyzing combinations of deficiencies to understand interactions among network components and carrying out additional genetic screens to identify new pathways involved in chemotaxis. A comprehensive understanding of this fascinating process should lead to control of pathological conditions such as inflammation and cancer metastasis. view moreResearch Areas: biochemistry, cell biology, chemotaxis, cancer, genomics, inflammation